• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Urine Test for Parkinson’s Disease

      Urine Test for Parkinson’s Disease

      Investigating Bacterial Motion for New Treatment Strategies

      Investigating Bacterial Motion for New Treatment Strategies

      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      siRNA as a COVID-19 Treatment

      siRNA as a COVID-19 Treatment

    • Radiology
      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

      Implanted Ultrasound Lets Chemo Access Brain

      Implanted Ultrasound Lets Chemo Access Brain

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

    • Cardiology
      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

      Pencil-on-Paper Wearable Sensor

      Pencil-on-Paper Wearable Sensor

      Cell Culture Chamber Mimics Mechanical States of Disease

      Cell Culture Chamber Mimics Mechanical States of Disease

      Chest Wearable Provides Key Heart Measurements

      Chest Wearable Provides Key Heart Measurements

    • Surgery
      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Soft Robotic Electrode Enables Minimally Invasive Placement

      Soft Robotic Electrode Enables Minimally Invasive Placement

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

    • Nanomedicine
      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Temperature Feedback for Prosthetic Limbs

      Temperature Feedback for Prosthetic Limbs

      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

      Knitted Glove Massages the Hand to Treat Edema

      Knitted Glove Massages the Hand to Treat Edema

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Cancer API Market Global Industry Size by Segments (Tinib, Rafenib, Parib, Lisib and Degib) Forecasts Till 2023

August 1st, 2018 Market Research Future Releases

Cancer API Market Overview:

This MRFR report offers a comprehensive analysis on the current Cancer API Market landscape, highlighting the recent historical growth of the market and its prospects over the next five years, until 2023.

The scope of the discussion covers five major API molecules categories namely, Tinib, Rafenib, Parib, Lisib, Degib, and Ciclib. Under the Tinib category, the molecules considered are Ponatinib, Brigatinib, Ruxolitinib, Erlotinib, Alectinib, Cobimetinib, Neratinib, Osimertinib, Acalabrutinib, Bosutinib, Crizotinib, Axitinib, Sunitinib, Ceritinib, Imatinib, Lapatinib, Afatinib, Cabozantinib, Dasatinib, Ibrutinib, Lenvatinib, and Gefitinib. Under Rafenib category the molecules considered include Sorafenib, Regorafenib, Vemurafenib, Dabrafenib, and Enasidenib.  Under Parib category the molecules considered are Olaparib, Rucaparib, and Niraparib. Under the Lisib category,  Idelalisib and Copanlisib have been profiled. Under the Degib category, Sonidegib and Vismodegib are the two major molecules reviewed. Under the Ciclib category molecules considered are Palbociclib, Ribociclib, and Abemaciclib.

Get Exclusive Sample Copy of Cancer API Market Report spread across 110 Premium Pages, Top 10 Companies Profile and Supported with 135 Tables and Figures is Now Available @ https://www.marketresearchfuture.com/sample_request/6243 .

Segmental Analysis

Cancer API molecules have been categorized into five major categories, such as Parib, Rafenib, Lisib, Degib, Tinib, and Ciclib. Under the Tinib category, the molecules included are Cobimetinib, Brigatinib, Ruxolitinib, Ponatinib, Erlotinib, Alectinib, Osimertinib, Bosutinib, Axitinib, Ceritinib, Sunitinib, Acalabrutinib, Lenvatinib, Imatinib, Neratinib, Lapatinib, Afatinib, Crizotinib, Cabozantinib, Dasatinib, Ibrutinib, and Gefitinib. In the Rafenib category, the molecules comprise of Regorafenib, Sorafenib, Dabrafenib, Vemurafenib, and Enasidenib. Under Parib category the molecules included are Rucaparib, Olaparib, and Niraparib. Under the Lisib category molecules, namely, Copanlisib and Idelalisib are considered. Under the Degib category, two major molecules are considered which are Vismodegib and Sonidegib. In the Ciclib category, molecules considered are Ribociclib, Palbociclib, and Abemaciclib.

Detailed Regional Analysis

The cancer API market varies from region to region and country to country on the basis of the approval process. All the five cancer API category molecules are recognized in the US. For instance, Brigatinib which is an oral, small molecule drug. It is well known as an Anaplastic Lymphoma Kinase (ALK) and Epidermal Growth Factor Receptor (EGFR) reversible dual inhibitor. Brigatinib had been created by Ariad Pharmaceuticals which is a subsidiary of Takeda Pharmaceutical Company Limited. The FDA had approved Brigatinib in April 2017 for the management of advanced ALK-positive metastatic non-small cell lung cancer. Takeda also has official rights for marketing this drug under the brand name “Alunbrig.” Furthermore, Neratinib which is also an oral, small molecule drug, was FDA approved in July 2017 for the treatment of HER2 breast cancer. Neratinib is also currently under investigation for use in other types of cancers, whereas in Europe and Japan the approval of molecules is in progress.

The demand for cancer API drugs in segments such as that of oncology is unprecedented. Growing demand for newly developed small molecule drugs is motivating the development of the Cancer API Market greatly due to the noteworthy developments in small molecule API manufacturing. As a result, contract manufacturers who are focused on the development and production of small-molecule APIs are witnessing significant growth. Both biopharmaceutical and small-molecule approaches have established track records for providing valuable therapeutic benefits to patients, due to their inherent advantages and disadvantages and will remain as complementary approaches for drug discovery in the market for the foreseeable future.

The pharmaceutical industry’s attention had significantly shifted away from the industry of chemistry and small molecules, to focus on monoclonal antibodies and recombinant proteins, which are highly demanded in the market. This shift had led to the migration of many CMOs to higher-value biologics manufacturing, mothballing plants or exiting the business completely thereby slowing down market growth. However, over the past few years, the attention of the pharmaceutical industry is reverting back to small molecule therapeutics increasingly. With big players exiting the business, the prospects for smaller or newer CMOs for small molecule cancer API manufacturing have improved and will increase in abundance in the global market.

Emergent worldwide demand for products, growing expansion of infrastructure in developing countries, and a couple of runaway successes launched in the market will generate more opportunities in the near future for market expansion. The reduced prices of drugs have boosted the volume consumption of the drug, as payers fund them freely, thus, increasing their accessibility. The resulting increase in API volume will create immense opportunities for API manufacturers in the cancer API market during the forecast period.

Competitive Analysis

The cancer API market is a vast market with numerous major market competitors functioning in many regions of the world. These competitors have come up with advanced drugs that are being used as a first line and second line therapy in the treatment of numerous types of cancers. Pfizer Inc, Eisai Ltd, Exelixis Inc, Bristol-Myers Squibb, F. Hoffman La Roche, AstraZeneca plc, Boehringer Ingelheim, Novartis AG, Bayer AG, Celgene, Clovis Oncology, Ariad Pharmaceuticals (Takeda),Eli Lilly & Company, AbbVie Inc., Gilead Lifesciences, Incyte Corporation, Puma Biotech, and TESARO, Inc, and others.

Get Discount @ https://www.marketresearchfuture.com/check-discount/6243 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Sign up and submit a press release

Sponsored

Packaging Compliance Labs (PCL) Celebrates Site Expansion in Grand Rapids, MI

Novel Approach to Assessing Lung Function Enables Improved Detection, Diagnosis and Treatment Decisions in Subject Exposed to Military Burn Pits

U.S. Patent Office Grants Additional Patent Protection For  Exoskeleton Focal-Force Angioplasty Platform

U.S. Patent Office Grants Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

interviews & reviews
Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email